Nettsider med emneord «Immunology»

The main focus of our research is regulation of adaptive immunity. We are particularly interested in signaling in activated and experienced T cells, as these cells influence individual susceptibility to autoimmune diseases as well as cancer. 

The immune system protects us against infection and cancer but may also overreact and cause autoimmune disease. Knowledge of molecular mechanisms regulating immune cell activation and control is needed to understand how autoimmune diseases may be prevented or treated.

The immunology group combines proteomics with molecular and cellular biology to investigate the regulation of innate and adaptive immunity, and pathogenic mechanisms involved in autoimmune disease and cancer.

The focus of the Immunbiology Laboratory is immune receptor biology and how this relates to the molecular mechanisms involved in autoimmune disease and cancer.

Our main research focus is on receptors that are expressed by cells of the innate immune system.

Increasing vaccine scepticism makes it more difficult to achieve herd immunity. We therefore need vaccines that protect each individual even better. Gunnveig Grødeland is now initiating the EU project VAXPRED.

The immune system stores enormous amounts of health and disease-relevant information. Researchers are attempting to decipher this information with the help of artificial intelligence, with the aim to develop novel diagnostic and therapeutic methods.

Protein in the blood did not have the function researchers believed in the interaction between two of the body's defence systems. Professor Tom Eirik Mollnes and colleagues thereby changed an established truth.

Raquel Bartolomé Casado is awarded the medal for her contribution to new knowledge about immunological memory in the gut. The findings from the doctoral dissertation may be important for the development of oral vaccines and treatment of intestinal diseases in the future.

Rapid diagnosis and treatment are crucial in the fight against tuberculosis. But today's testing methods are not good enough. Tests based on blood biomarkers may be the solution.